Live
Home·Deals·Pharmaceuticals·ChrysCapital acquires Novartis India
SEO URLwww.firestrike.ai/deals/novartis-india-chryscapital-acquisition-2026-3
acquisitionAnnounced · Feb 21, 2026PharmaceuticalsSource · CredibleArticle · Factual
Novartis India
ChrysCapital
Novartis India · ChrysCapital

ChrysCapital acquires Novartis India

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
Target
Novartis India
Novartis India
Basel, Basel-City
Acquirer
ChrysCapital
ChrysCapital
Financial Stake
Status
Announced

ChrysCapital agreed to acquire Novartis India. Reported deal value: Undisclosed. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Basel, Basel-City, Switzerland.

This page summarizes publicly available information about the transaction as of 2026-02-21. Figures and status may change as filings and press coverage update.

Key facts : ChrysCapital acquires stake in Novartis India

Deal timeline

Announced
Feb 21, 2026 · tradingview.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Pharmaceuticals. Figures and status may change as sources update.

Sources: tradingview.com · Primary article · FireStrike proprietary index